ArticleCancer immunology, immunotherapy : CII2014

An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression.

Pengfei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.